Beers-listed drug classes [24] | n drugs | % of n = 579 patients | Possible clinical consequences |
Benzodiazepines + Zolpidem | 114 | 19.7% | cognitive impairment, delirium, falls/fractures |
NSAIDs + COX-2-inhibitors (Coxibe) | 38 | 6.6% | bleeding, nephrotoxicity |
Antiarrhythmics | 37 | 6.4% | toxicity, QT alteration |
Alpha-blockers | 30 | 5.2% | hypotension |
Diuretics + Spironolacton | 29 | 5.0% | ↑ potassium |
CCBs | 26 | 4.5% | myocardial ischemia, hypotension |
Antithrombotic drugs, mainly Ticlopidine | 22 | 3.8% | toxicity, safer alternatives available |
Antidepressants and antipsychotics | 20 | 3.5% | anticholinergic effects, cardio-vascular events, hyponatriaemia |
Cardiac glycosides | 13 | 2.2% | toxicity, safer alternatives available |
Da or Xa drug-drug interactions [26] | n DDIs | % of n = 579 patients | Possible clinical consequences |
Acenocoumarol/Warfarin - Allopurinol | 32 | 5.5% | ↑ risk of bleeding |
Alendronate - Calcium carbonate | 29 | 5.0% | ↓ absorption of alendronate |
Amlodipine/Lercanidipine - Simvastatin | 27 | 4.7% | myopathy/ rhabdomyolysis |
Levothyroxine - Calcium carbonate | 26 | 4.5% | ↓ absorption of levothyroxine |
Allopurinol – Ramipril/Lisinopril/Enalapril | 21 | 3.6% | allergic reactions to allopurinol |
Bisoprolol - Tamsulosin | 18 | 3.1% | hypotension |
Acenocoumarol/Warfarin - Acetylsalicylic acid | 16 | 2.8% | ↑ risk of bleeding |
Ibuprofen/Diclofenac - Acetylsalicylic acid | 15 | 2.6% | ↑ risk of bleeding |
Acetylsalicylic acid - Etoricoxib | 12 | 2.1% | ↑ toxicity of etoricoxib, bleeding |
Clopidogrel - Pantoprazole | 11 | 1.9% | ↓ effectiveness of clopidogrel |
Bisoprolol - Doxazosin | 9 | 1.6% | hypotension |
Ibuprofen - Warfarin | 9 | 1.6% | ↑ risk of bleeding |
Ibuprofen - Furosemide | 8 | 1.4% | nephrotoxicity |
Prednison - Calcium carbonate | 7 | 1.2% | ↓ absorption of prednison |
Drug classes involved in Da or Xa DDIs | n DDIs | % of n = 579 patients |  |
Antithrombotic / anticoagulant drugs | 176 | 30.4% | Â |
Antidepressants / antipsychotics | 134 | 23.1% | Â |
Calcium carbonate | 77 | 13.3% | Â |
Beta-blockers | 74 | 12.8% | Â |
Alpha-blockers | 72 | 12.4% | Â |
Statins | 64 | 11.1% | Â |
NSAIDs + COX-2-inhibitors (Coxibe) | 62 | 10.7% | Â |
ARBs/ACE-inhibitors | 61 | 10.5% | Â |
CCBs | 54 | 9.3% | Â |
Drugs for gout treatment-Allopurinol | 48 | 8.3% | Â |